市場調査レポート

商品コード

1318909

血管損傷治療市場：傷害別、治療別、エンドユーザー別-2023-2030年の世界予測

Vascular Injury Treatment Market by Injury, Treatment, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 754,948円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 913,918円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,072,888円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,390,828円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=158.97円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

血管損傷治療の世界市場は、2023年に215億1,000万米ドル、CAGR13.74%で大幅な成長が予測され、2030年には530億4,000万米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の血管損傷治療市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.血管損傷治療の世界市場規模および予測は？

2.予測期間中、世界の血管損傷治療市場を形成するCOVID-19の阻害要因と影響は？

3.血管損傷治療の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.血管損傷治療の世界市場における競争戦略は？

5.血管損傷治療の世界市場における技術動向と規制の枠組みは？

6.血管損傷治療の世界市場における主要ベンダーの市場シェアは？

7.血管損傷治療の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 血管損傷手術の発生率の上昇
  - 交通事故、切り傷、暴力の増加による外傷の発生の増加
  - 心臓関連疾患の治療法を提供するために病院との連携が増加
- 抑制要因
  - 血管損傷治療に関連する高コスト
- 機会
  - 新興諸国における医療ツーリズムの成長
  - テクノロジーのますますの進歩
- 課題
  - 血管損傷治療に関連する副作用
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章血管損傷治療市場怪我別

動脈瘤と仮性動脈瘤
動静脈瘻
挫傷または内膜皮弁
裂傷または切断
けいれん
血栓症

第7章血管損傷治療市場治療別

バイパスグラフト
追加の解剖学的バイパス
外側動脈縫合術または静脈縫合術
パッチ血管形成術
血栓除去術

第8章血管損傷治療市場：エンドユーザー別

外来手術センター
病院

第9章南北アメリカの血管損傷治療市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第10章アジア太平洋地域の血管損傷治療市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第11章欧州・中東・アフリカの血管損傷治療市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第12章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第13章掲載企業一覧

第14章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. VASCULAR INJURY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. VASCULAR INJURY TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2022 VS 2030 (%)
FIGURE 5. VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 6. VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 7. VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. VASCULAR INJURY TREATMENT MARKET DYNAMICS
FIGURE 9. VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. VASCULAR INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 5. VASCULAR INJURY TREATMENT MARKET SIZE, BY ANEURYSM & PSEUDOANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VASCULAR INJURY TREATMENT MARKET SIZE, BY CONTUSION OR INTIMAL FLAP, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VASCULAR INJURY TREATMENT MARKET SIZE, BY LACERATION OR TRANSECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VASCULAR INJURY TREATMENT MARKET SIZE, BY SPASM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 12. VASCULAR INJURY TREATMENT MARKET SIZE, BY BYPASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VASCULAR INJURY TREATMENT MARKET SIZE, BY EXTRA ANATOMIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VASCULAR INJURY TREATMENT MARKET SIZE, BY LATERAL ARTERIORRHAPHY OR VENORRHAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VASCULAR INJURY TREATMENT MARKET SIZE, BY PATCH ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 31. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 32. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 34. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 48. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 51. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 57. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 75. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 88. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 91. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 94. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 97. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 103. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 112. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 115. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 118. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 130. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 139. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 148. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 149. VASCULAR INJURY TREATMENT MARKET LICENSE & PRICING

Product Code: MRR-034B5003037D

The Global Vascular Injury Treatment Market is forecasted to grow significantly, with a projected USD 21.51 billion in 2023 at a CAGR of 13.74% and expected to reach a staggering USD 53.04 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vascular Injury Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vascular Injury Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Injury, market is studied across Aneurysm & Pseudoaneurysm, Arteriovenous Fistula, Contusion or Intimal Flap, Laceration or Transection, Spasm, and Thrombosis. The Contusion or Intimal Flap is projected to witness significant market share during forecast period.

Based on Treatment, market is studied across Bypass Graft, Extra Anatomic Bypass, Lateral Arteriorrhaphy or Venorrhaphy, Patch Angioplasty, and Thrombectomy. The Patch Angioplasty is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Center and Hospital. The Ambulatory Surgical Center is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vascular Injury Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vascular Injury Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vascular Injury Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vascular Injury Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Vascular Injury Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Vascular Injury Treatment Market?

6. What is the market share of the leading vendors in the Global Vascular Injury Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Vascular Injury Treatment Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Vascular Injury Treatment Market, by Injury, 2022 vs 2030
4.3. Vascular Injury Treatment Market, by Treatment, 2022 vs 2030
4.4. Vascular Injury Treatment Market, by End-User, 2022 vs 2030
4.5. Vascular Injury Treatment Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising incidence of vascular injury surgeries
  - 5.1.1.2. Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
  - 5.1.1.3. Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with the vascular injury treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Growing medical tourism in developing countries
  - 5.1.3.2. Increasing advancement in technologies
- 5.1.4. Challenges
  - 5.1.4.1. Side effects associated with vascular injury treatment
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Vascular Injury Treatment Market, by Injury

6.1. Introduction
6.2. Aneurysm & Pseudoaneurysm
6.3. Arteriovenous Fistula
6.4. Contusion or Intimal Flap
6.5. Laceration or Transection
6.6. Spasm
6.7. Thrombosis

7. Vascular Injury Treatment Market, by Treatment

7.1. Introduction
7.2. Bypass Graft
7.3. Extra Anatomic Bypass
7.4. Lateral Arteriorrhaphy or Venorrhaphy
7.5. Patch Angioplasty
7.6. Thrombectomy

8. Vascular Injury Treatment Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgical Center
8.3. Hospital

9. Americas Vascular Injury Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Vascular Injury Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Vascular Injury Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

血管損傷治療市場：傷害別、治療別、エンドユーザー別-2023-2030年の世界予測

Vascular Injury Treatment Market by Injury, Treatment, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 血管損傷治療市場怪我別

第7章 血管損傷治療市場治療別

第8章 血管損傷治療市場：エンドユーザー別

第9章 南北アメリカの血管損傷治療市場

第10章 アジア太平洋地域の血管損傷治療市場

第11章 欧州・中東・アフリカの血管損傷治療市場

第12章 競合情勢

第13章 掲載企業一覧

第14章 付録